Droia Ventures reposted this
We are pleased to introduce Hillstar Bio, a pioneering biotechnology company dedicated to transforming the treatment of autoimmune diseases. Today, we launched with a $67 million Series A financing led by a syndicate of experienced investors and shareholders from the U.S., Europe, and Asia, including Droia Ventures, Frazier Life Sciences, Novo Holdings, LifeArc Ventures, and Hummingbird Bioscience. Developed by a world-class team of experts, Hillstar’s approach targets and depletes pathogenic immune cells while preserving healthy ones. We aim to reset the immune system and provide patients with durable therapeutic responses, potentially reducing the need for long-term immunosuppressive treatments. Learn more about Hillstar Bio here: https://bit.ly/4iYfiBi #hillstarbio #precisionimmunotherapy #precisionimmunology #autoimmunedisease #immunology #trbv9 #invisibleillness #chronicillness #axspa
Exciting to see the concept of immune reset being taken to T cells. There is so much hype around reset after wiping out the entire B cell compartment; targeting pathogenic cells only is the logical next step.
Congrats, Robert and Hillstar team!
Congratulations Robert, Lauren and Mitchell!
Congratulations on the launch, Hillstar Bio! #MassBioMember
Congratulations Hillstar Bio team on your launch and Series A raise! I look forward to following your precision approach to immunotherapy and the impact it will have for patients with autoimmune diseases. Wishing you every success! #Immunotherapy #Autoimmune #BiotechInnovation
Congratulations Lauren Mifflin and team
Congrats Robert!
Congratulations, exciting things ahead!
Congrats! 🎉
Biotech Executive | Entrepreneur
3wCongratulations Robert!